Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease ; volume:17 ; number:1 ; day:12 ; month:5 ; year:2022 ; pages:1-3 ; date:12.2022
Molecular neurodegeneration ; 17, Heft 1 (12.5.2022), 1-3, 12.2022
- Urheber
-
Zhao, Yingjun
Xu, Huaxi
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-022-00541-z
- URN
-
urn:nbn:de:101:1-2022071721020254193137
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zhao, Yingjun
- Xu, Huaxi
- SpringerLink (Online service)
Ähnliche Objekte (12)
Microglial Activation in Alzheimer’s Disease
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Alzheimer disease : therapeutic strategies
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
Microglial Activation in Alzheimer’s Disease
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Alzheimer disease : therapeutic strategies
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
Microglial Activation in Alzheimer’s Disease
Glutamine metabolism modulates microglial NLRP3 inflammasome activity through mitophagy in Alzheimer’s disease
Microglial immunophenotype in dementia with Alzheimer’s pathology
Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease
Microglial IKKß Defiency Ameliorates Alzheimer´s Disease-Realted Symptoms and Pathology
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Ultrastructural evidence of microglial heterogeneity in Alzheimer’s disease amyloid pathology
Müller cell degeneration and microglial dysfunction in the Alzheimer’s retina
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Alzheimer disease : therapeutic strategies
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models